Cbl-b-IN-5

CAS No. 2368835-59-8

Cbl-b-IN-5( —— )

Catalog No. M36958 CAS No. 2368835-59-8

Cbl-b-IN-5 is a potent CPL-B inhibitor with IC50 values between 3 and 10 μM. Cbl-b-IN-5 has been used to study cancer and diseases related to the immune system.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 116 Get Quote
5MG 178 Get Quote
10MG 278 Get Quote
25MG 548 Get Quote
50MG 1003 Get Quote
100MG 1404 Get Quote
500MG 2817 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cbl-b-IN-5
  • Note
    Research use only, not for human use.
  • Brief Description
    Cbl-b-IN-5 is a potent CPL-B inhibitor with IC50 values between 3 and 10 μM. Cbl-b-IN-5 has been used to study cancer and diseases related to the immune system.
  • Description
    Cbl-b-IN-5 (compound 6) is a Cbl-b inhibitor (IC50=3-10 μM). Cbl-b-IN-5 has the potential to be used in the study of cancer and related diseases amenable to immune system modulation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2368835-59-8
  • Formula Weight
    339.42
  • Molecular Formula
    C17H17N5OS
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (294.63 mM; Ultrasonic )
  • SMILES
    O=C(NC1=CC=CC(=C1)C(SC2=NN=CN2C)C)C3=NC=CC=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Paul A. Barsanti, et al. Inhibitors of cbl-b and methods of use thereof. Patent WO2019148005A1.
molnova catalog
related products
  • AU-224

    AU-224 is an orally available benzamide derivative that is a potent gastrointestinal prokinetic.

  • Echimidine

    Echimidine, a major hepatotoxic dehydropyrrolizidine alkaloid produced by E. plantagineum, in the honey (780 ng/g) and in the subsequent mead samples (236-540 ng/mL). Echimidine-N-Oxide has antifungal activity.

  • Obtusifoliol

    Obtusifoliol is a metabolic intermediate of sterols made by certain fungis, can be converted to Delta8,14-Sterol by enzyme ERG11 (CYP51F1).